Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 1
2006 2
2007 5
2008 5
2009 2
2010 2
2011 3
2012 2
2013 3
2014 7
2015 4
2016 9
2017 6
2018 4
2019 3
2020 3
2021 9
2022 5
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Darier disease responding to apremilast: Report of two cases.
Afroditi Kleidona I, Agiasofitou E, Tsiogka A, Chorti M, Gregoriou S, Stratigos A, Rigopoulos D, Kontochristopoulos G. Afroditi Kleidona I, et al. Among authors: kontochristopoulos g. Indian J Dermatol Venereol Leprol. 2024 Jan 4:1-3. doi: 10.25259/IJDVL_83_2023. Online ahead of print. Indian J Dermatol Venereol Leprol. 2024. PMID: 38314981 Free article. No abstract available.
Clinical characteristics and treatment options for multifocal hyperhidrosis in a single-centre real-world population.
Markantoni V, Tsiogka A, Agiasofitou E, Platsidaki E, Kouris A, Kontochristopoulos G, Antoniou C, Stratigos A, Gregoriou S. Markantoni V, et al. Among authors: kontochristopoulos g. J Eur Acad Dermatol Venereol. 2023 Nov;37(11):e1310-e1313. doi: 10.1111/jdv.19303. Epub 2023 Jul 14. J Eur Acad Dermatol Venereol. 2023. PMID: 37415361 No abstract available.
The Impact of Treatment with IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients with Plaque Psoriasis and/or Psoriatic Arthritis: A Systematic Review.
Tsiogka A, Gregoriou S, Stratigos A, Soulaidopoulos S, Rompoti N, Panagakis P, Papoutsaki M, Kostakis P, Kontochristopoulos G, Tsioufis K, Campanati A, Offidani A, Vlachopoulos C, Rigopoulos D. Tsiogka A, et al. Among authors: kontochristopoulos g. Biomedicines. 2023 Jan 23;11(2):318. doi: 10.3390/biomedicines11020318. Biomedicines. 2023. PMID: 36830855 Free PMC article. Review.
Botulinum Toxin Type A for Treatment of Forehead Hyperhidrosis: Multicenter Clinical Experience and Review from Literature.
Campanati A, Martina E, Gregoriou S, Kontochristopoulos G, Paolinelli M, Diotallevi F, Radi G, Bobyr I, Marconi B, Gualdi G, Amerio P, Offidani A. Campanati A, et al. Among authors: kontochristopoulos g. Toxins (Basel). 2022 May 27;14(6):372. doi: 10.3390/toxins14060372. Toxins (Basel). 2022. PMID: 35737033 Free PMC article. Clinical Trial.
The pharmacological treatment and management of hyperhidrosis.
Campanati A, Gregoriou S, Milia-Argyti A, Kontochristopoulos G, Radi G, Diotallevi F, Martina E, Offidani A. Campanati A, et al. Among authors: kontochristopoulos g. Expert Opin Pharmacother. 2022 Jul;23(10):1217-1231. doi: 10.1080/14656566.2022.2083499. Epub 2022 Jul 10. Expert Opin Pharmacother. 2022. PMID: 35686667 Review.
73 results